Justin Stebbing
Imperial College London
H-index: 88
Europe-United Kingdom
Top articles of Justin Stebbing
A phase 1/2 clinical trial of invariant natural killer T cell therapy in moderate-severe acute respiratory distress syndrome
Nature Communications
2024/2/6
Genes and Race in Colon Cancer
2024/2/1
Justin Stebbing
H-Index: 51
Development of a Novel Pyroptosis-Associated lncRNA Biomarker Signature in Lung Adenocarcinoma
Molecular biotechnology
2024/2
LMTK3 gene expression and the molecular landscape of colorectal cancer (CRC).
2024/1/20
An exosome mRNA-related gene risk model to evaluate the tumor microenvironment and predict prognosis in hepatocellular carcinoma
BMC Medical Genomics
2024
Circulating tumour DNA dynamics during alternating chemotherapy and hormonal therapy in metastatic breast cancer: the ALERT study
Breast Cancer Research and Treatment
2024/4/6
Qi Guo
H-Index: 10
Justin Stebbing
H-Index: 51
Serial Postoperative Circulating Tumor DNA Assessment Has Strong Prognostic Value During Long-Term Follow-Up in Patients With Breast Cancer
JCO Precision Oncology
2024/4
The safety and potential efficacy of exosomes overexpressing CD24 (EXO-CD24) in mild-moderate COVID-19 related ARDS
Respiratory Research
2024/4/1
Justin Stebbing
H-Index: 51
Sotirios Tsiodras
H-Index: 35
Polo-like Kinase 1 Inhibition in KRAS-Mutated Metastatic Colorectal Cancer
Clinical Cancer Research
2024/3/28
Justin Stebbing
H-Index: 51
Kinome‐Wide Synthetic Lethal Screen Identifies PANK4 as a Modulator of Temozolomide Resistance in Glioblastoma
Advanced Science
2024/2/14
A bile-based microRNA signature for differentiating malignant from benign pancreaticobiliary disease
Experimental hematology & oncology
2023/12/1
A prognostic model of drug tolerant persister-related genes in lung adenocarcinoma based on single cell and bulk RNA sequencing data
Heliyon
2023/11/1
The mutational landscape of the adult healthy parous and nulliparous human breast
Nature Communications
2023/9/6
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
2023/8/18
Patrizia Diana
H-Index: 27
Justin Stebbing
H-Index: 51
Six-Year Survival Outcomes for Patients with HER2-Positive Early Breast Cancer Treated with CT-P6 or Reference Trastuzumab: Observational Follow-Up Study of a Phase 3 …
BioDrugs
2023/5
Justin Stebbing
H-Index: 51
Jaeyong Lee
H-Index: 12
Nahyun Kim
H-Index: 2
Sang Joon Lee
H-Index: 34
Sunghyun Kim
H-Index: 2
Kinome-wide synthetic lethal screen identifies PANK4 as modulator of resistance in glioblastoma
2023/3/27
Comparison of phenomics and cfDNA in a large breast screening population: The Breast Screening and Monitoring Study (BSMS)
Oncogene
2023/1/24
A pyroptosis‐related lncRNA signature in bladder cancer
Cancer medicine
2023/3
Design and reporting of phase III oncology trials with prospective biomarker validation
JNCI: Journal of the National Cancer Institute
2023/2/1
The inhibitory properties of a novel, selective LMTK3 kinase inhibitor
International Journal of Molecular Sciences
2023/1/3